chr3-190387662-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001378492.1(CLDN16):​c.-93-575C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,112 control chromosomes in the GnomAD database, including 2,317 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.17 ( 2317 hom., cov: 32)

Consequence

CLDN16
NM_001378492.1 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.77

Publications

1 publications found
Variant links:
Genes affected
CLDN16 (HGNC:2037): (claudin 16) Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. It is found primarily in the kidneys, specifically in the thick ascending limb of Henle, where it acts as either an intercellular pore or ion concentration sensor to regulate the paracellular resorption of magnesium ions. Defects in this gene are a cause of primary hypomagnesemia, which is characterized by massive renal magnesium wasting with hypomagnesemia and hypercalciuria, resulting in nephrocalcinosis and renal failure. This gene and the CLDN1 gene are clustered on chromosome 3q28. [provided by RefSeq, Jun 2010]
CLDN16 Gene-Disease associations (from GenCC):
  • renal hypomagnesemia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 3-190387662-C-T is Benign according to our data. Variant chr3-190387662-C-T is described in ClinVar as Benign. ClinVar VariationId is 1286736.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.196 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378492.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLDN16
NM_001378492.1
c.-93-575C>T
intron
N/ANP_001365421.1Q9Y5I7
CLDN16
NM_001378493.1
c.-93-575C>T
intron
N/ANP_001365422.1Q9Y5I7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLDN16
ENST00000880223.1
c.-93-575C>T
intron
N/AENSP00000550282.1
CLDN16
ENST00000880225.1
c.-93-575C>T
intron
N/AENSP00000550284.1
CLDN16
ENST00000880227.1
c.-93-575C>T
intron
N/AENSP00000550286.1

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
25418
AN:
151994
Hom.:
2321
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.122
Gnomad AMI
AF:
0.389
Gnomad AMR
AF:
0.147
Gnomad ASJ
AF:
0.175
Gnomad EAS
AF:
0.147
Gnomad SAS
AF:
0.0893
Gnomad FIN
AF:
0.190
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.199
Gnomad OTH
AF:
0.181
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.167
AC:
25408
AN:
152112
Hom.:
2317
Cov.:
32
AF XY:
0.165
AC XY:
12279
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.122
AC:
5069
AN:
41516
American (AMR)
AF:
0.147
AC:
2244
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
609
AN:
3472
East Asian (EAS)
AF:
0.146
AC:
754
AN:
5160
South Asian (SAS)
AF:
0.0887
AC:
428
AN:
4824
European-Finnish (FIN)
AF:
0.190
AC:
2009
AN:
10558
Middle Eastern (MID)
AF:
0.197
AC:
58
AN:
294
European-Non Finnish (NFE)
AF:
0.199
AC:
13504
AN:
67988
Other (OTH)
AF:
0.179
AC:
378
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1055
2110
3165
4220
5275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.187
Hom.:
4545
Bravo
AF:
0.166
Asia WGS
AF:
0.0800
AC:
281
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.048
DANN
Benign
0.53
PhyloP100
-1.8
PromoterAI
0.0088
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13080849; hg19: chr3-190105451; API